Enanta Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US29251M1062

SecurityENTA / Enanta Pharmaceuticals, Inc.
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership203,252 shares
Latest Disclosed Value $ 2,566,230
Dimensional Fund Advisors Lp reports 3.95% decrease in ownership of ENTA / Enanta Pharmaceuticals, Inc.

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 203,252 shares of Enanta Pharmaceuticals, Inc. (US:ENTA) valued at $2,567,073 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 211,614 shares of Enanta Pharmaceuticals, Inc.. This represents a change in shares of -3.95% during the quarter. The current value of the position is $2,284,552 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F ENANTA PHARMACEUTICALS COM 29251M106 203,252 -8,362 -3.95 2,566 -23.10 0.0005
2026-02-12 2025-12-31 13F ENANTA PHARMACEUTICALS COM 29251M106 211,614 -58,454 -21.64 3,337 3.15 0.0007
2025-11-12 2025-09-30 13F ENANTA PHARMACEUTICALS COM 29251M106 270,068 -7,572 -2.73 3,235 54.19 0.0007
2025-08-12 2025-06-30 13F ENANTA PHARMACEUTICALS COM 29251M106 277,640 -4,662 -1.65 2,099 34.66 0.0005
2025-05-13 2025-03-31 13F ENANTA PHARMACEUTICALS COM 29251M106 282,302 -14,804 -4.98 1,558 -8.78 0.0004
2025-02-13 2024-12-31 13F ENANTA PHARMACEUTICALS COM 29251M106 297,106 102,646 52.79 1,708 -15.19 0.0004
2024-11-07 2024-09-30 13F ENANTA PHARMACEUTICALS COM 29251M106 194,460 65,398 50.67 2,014 20.38 0.0005
2024-08-09 2024-06-30 13F ENANTA PHARMACEUTICALS COM 29251M106 129,062 -60,194 -31.81 1,674 -49.36 0.0004
2024-05-10 2024-03-31 13F ENANTA PHARMACEUTICALS COM 29251M106 189,256 9,693 5.40 3,304 95.62 0.0009
2024-02-07 2023-12-31 13F ENANTA PHARMACEUTICALS COM 29251M106 179,563 -17,190 -8.74 1,690 -23.12 0.0005
2023-11-09 2023-09-30 13F ENANTA PHARMACEUTICALS COM 29251M106 196,753 -248,689 -55.83 2,198 -76.95 0.0007
2023-08-09 2023-06-30 13F ENANTA PHARMACEUTICALS COM 29251M106 445,442 -93,247 -17.31 9,532 -56.24 0.0030
2023-05-12 2023-03-31 13F ENANTA PHARMACEUTICALS COM 29251M106 538,689 -4,877 -0.90 21,784 87,032.00 0.0073
2023-02-09 2022-12-31 13F ENANTA PHARMACEUTICALS COM 29251M106 543,566 33,688 6.61 25 -99.91 0.0075
2022-11-10 2022-09-30 13F ENANTA PHARMACEUTICALS COM 29251M106 509,878 -13,831 -2.64 26,449 6.84 0.0102
2022-08-12 2022-06-30 13F ENANTA PHARMACEUTICALS COM 29251M106 523,709 -69,811 -11.76 24,756 -41.40 0.0089
2022-05-13 2022-03-31 13F ENANTA PHARMACEUTICALS COM 29251M106 593,520 -8,218 -1.37 42,244 -6.12 0.0130
2022-02-09 2021-12-31 13F ENANTA PHARMACEUTICALS COM 29251M106 601,738 -9,128 -1.49 44,998 29.67 0.0136
2021-11-12 2021-09-30 13F ENANTA PHARMACEUTICALS COM 29251M106 610,866 -33,922 -5.26 34,703 22.29 0.0112
2021-08-12 2021-06-30 13F ENANTA PHARMACEUTICALS COM 29251M106 644,788 57,292 9.75 28,377 -2.06 0.0090
2021-05-14 2021-03-31 13F ENANTA PHARMACEUTICALS COM 29251M106 587,496 -83,725 -12.47 28,974 2.53 0.0096
2021-03-08 2020-12-31 13F/A-2 ENANTA PHARMACEUTICALS COM 29251M106 671,221 -28,792 -4.11 28,258 -11.82 0.0102
2021-02-11 2020-12-31 13F ENANTA PHARMACEUTICALS COM 29251M106 671,221 -28,792 28,258 10,205.2876
2020-11-12 2020-09-30 13F ENANTA PHARMACEUTICALS COM 29251M106 700,013 -16,825 -2.35 32,045 -10.96 0.0136
2020-08-13 2020-06-30 13F ENANTA PHARMACEUTICALS COM 29251M106 716,838 1,335 0.19 35,991 -2.19 0.0158
2020-05-14 2020-03-31 13F ENANTA PHARMACEUTICALS COM 29251M106 715,503 14,712 2.10 36,797 -15.01 0.0192
2020-02-14 2019-12-31 13F ENANTA PHARMACEUTICALS COM 29251M106 700,791 32,100 4.80 43,295 7.77 0.0158
2019-11-12 2019-09-30 13F ENANTA PHARMACEUTICALS COM 29251M106 668,691 42,633 6.81 40,175 -23.95 0.0156
2019-08-13 2019-06-30 13F ENANTA PHARMACEUTICALS COM 29251M106 626,058 -2,955 -0.47 52,827 -12.08 0.0205
2019-08-12 2019-03-31 13F/A-2 ENANTA PHARMACEUTICALS COM 29251M106 629,013 5,383 0.86 60,083 36.02 0.0239
2019-05-10 2019-03-31 13F ENANTA PHARMACEUTICALS COM 29251M106 629,013 5,383 60,083
2019-02-26 2018-12-31 13F/A-1 ENANTA PHARMACEUTICALS COM 29251M106 623,630 19,624 3.25 44,172 -14.43 0.0200
2019-02-13 2018-12-31 13F ENANTA PHARMACEUTICALS COM 29251M106 623,630 19,624 44,172
2018-11-13 2018-09-30 13F ENANTA PHARMACEUTICALS COM 29251M106 604,006 10,159 1.71 51,620 -25.00 0.0196
2018-08-10 2018-06-30 13F ENANTA PHARMACEUTICALS COM 29251M106 593,847 537 0.09 68,825 43.37 0.0274
2018-05-11 2018-03-31 13F ENANTA PHARMACEUTICALS COM 29251M106 593,310 32,640 5.82 48,005 45.91 0.0200
2018-02-12 2017-12-31 13F ENANTA PHARMACEUTICALS COM 29251M106 560,670 -1,724 -0.31 32,901 25.00 0.0136
2017-11-13 2017-09-30 13F ENANTA PHARMACEUTICALS COM 29251M106 562,394 7,617 1.37 26,320 31.86 0.0115
2017-08-11 2017-06-30 13F ENANTA PHARMACEUTICALS COM 29251M106 554,777 141,688 34.30 19,961 56.89 0.0092
2017-05-12 2017-03-31 13F ENANTA PHARMACEUTICALS COM 29251M106 413,089 233,265 129.72 12,723 111.21 0.0061
2017-02-09 2016-12-31 13F ENANTA PHARMACEUTICALS COM 29251M106 179,824 152,511 558.38 6,024 729.75 0.0030
2016-11-10 2016-09-30 13F ENANTA PHARMACEUTICALS COM 29251M106 27,313 1,700 6.64 726 28.50 0.0004
2016-08-09 2016-06-30 13F ENANTA PHARMACEUTICALS COM 29251M106 25,613 0 0.00 565 -24.87 0.0003
2016-05-13 2016-03-31 13F ENANTA PHARMACEUTICALS COM 29251M106 25,613 100 0.39 752 -10.79 0.0005
2016-02-10 2015-12-31 13F ENANTA PHARMACEUTICALS COM 29251M106 25,513 300 1.19 843 -7.36 0.0005
2015-11-13 2015-09-30 13F ENANTA PHARMACEUTICALS COM 29251M106 25,213 1,000 4.13 910 -16.36 0.0006
2015-08-14 2015-06-30 13F ENANTA PHARMACEUTICALS COM 29251M106 24,213 13,012 116.17 1,088 217.20 0.0007
2015-05-14 2015-03-31 13F ENANTA PHARMACEUTICALS COM 29251M106 11,201 11,201 343 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.